Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

Myocarditis

Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,325

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627

Preliminary evidence on long COVID in children

Buonsenso, D., Munblit, D., Rose, C. D., Sinatti, D., Ricchiuto, A., Carfì, A., & Valentini, P. (2021) · Acta Paediatrica · doi:10.1111/apa.15870 · Cited by 508

Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2

Payne, A. B., Gilani, Z., Godfred‐Cato, S., Belay, E. D., Feldstein, L. R., Patel, M. M., Randolph, A. G., Newhams, M. M., Thomas, D., Magleby, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16420 · Cited by 395

The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

Baggs, J. M., Gee, J. M., Lewis, E. M., Fowler, G. L., Benson, P. J., Lieu, T. A., Naleway, A. L., Klein, N. P., Baxter, R. P., Belongia, E. A., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722h · Cited by 349

The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood

Kytö, V., Sipilä, J., & Rautava, P. (2013) · Heart · doi:10.1136/heartjnl-2013-304449 · Cited by 124

Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007–2016

Vasudeva, R., Bhatt, P. J., Lilje, C., Desai, P., Amponsah, J. K., Umscheid, J., Parmar, N. G., Bhatt, N. S., Adupa, R., Pagad, S., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.03.019 · Cited by 53

Multisystem Inflammatory-like Syndrome in a Child Following COVID-19 mRNA Vaccination

Poussaint, T. Y., LaRovere, K. L., Newburger, J. W., Chou, J., Nigrovic, L. E., Novak, T., & Randolph, A. G. (2021) · Vaccines · doi:10.3390/vaccines10010043 · Cited by 30

Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations

Power, J. R., Keyt, L. K., & ADLER, E. D. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2066522 · Cited by 32

COVID‐19: Clinical status of vaccine development to date

Kumar, S., Basu, M., Ghosh, P., Ansari, A., & Ghosh, M. K. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15552 · Cited by 32

Acute Myocarditis after COVID-19 vaccination: A case report

Schmitt, P., Demoulin, R., Poyet, R., Capilla, E., Rohel, G., Pons, F., Jégo, C., Sidibe, S., Druelle, A., Brocq, F.-X., et al. (2021) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.10.003 · Cited by 30

Cardiovascular Complications of COVID-19 Vaccines

Liu, R., Pan, J., Zhang, C., & Sun, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.840929 · Cited by 28

COVID-19 vaccination in Israel

Muhsen, K., & Cohen, D. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.07.041 · Cited by 29

Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA

Milano, G. A., Gal, J., Creisson, A., & Chamorey, E. (2021) · Future Virology · doi:10.2217/fvl-2021-0280 · Cited by 31

Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years

Hu, M., Wong, H., Feng, Y., Lloyd, P. C., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., Mitra, M., et al. (2023) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2023.1440 · Cited by 29

Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Yang, X. S., Chen, M., Cao, L., & Zhao, M. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2270194 · Cited by 28

Tolosa-Hunt Syndrome Presenting After COVID-19 Vaccination

Chuang, T.-Y., Burda, K., Teklemariam, E., & Athar, K. (2021) · Cureus · doi:10.7759/cureus.16791 · Cited by 28

Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations

Murdaca, G., Noberasco, G., Olobardi, D., Lunardi, C., Maule, M., Delfino, L., Triggiani, M., Cardamone, C., Benfaremo, D., Moroncini, G., et al. (2021) · Vaccines · doi:10.3390/vaccines9121426 · Cited by 28

Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

He, Y., Ouyang, J., Hu, X.-D., Ni, W., Jiang, Z., Bian, N., & Wang, J. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.892 · Cited by 27

A review of the safety and efficacy of current COVID-19 vaccines

Huang, Z., Su, Y., Zhang, T., & Xia, N. (2022) · Frontiers of Medicine · doi:10.1007/s11684-021-0893-y · Cited by 28

Myocarditis Following COVID-19 Vaccination: A Systematic Review (October 2020–October 2021)

Lee, S. Y. A., Balakrishnan, I. D., Khoo, C. Y., Ng, C. T., Loh, J. K., Chan, L. L., Teo, L. L., & Sim, D. K. L. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.02.002 · Cited by 27

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

Joshi, G., Borah, P., Thakur, S., Sharma, P., Mayank, M., & Ramarao, P. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1995283 · Cited by 28

The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination

Rudan, I., Adeloye, D., Katikireddi, S. V., Murray, J., Simpson, C. R., Shah, S. A., Robertson, C., & Sheikh, A. (2021) · Journal of Global Health · doi:10.7189/jogh.11.01011 · Cited by 24

Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series

Park, D. Y., An, S., Kaur, A., Malhotra, S., & Vij, A. (2022) · Clinical Cardiology · doi:10.1002/clc.23828 · Cited by 25

Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms

Aksoyalp, Z. Ş., & Samur, D. N. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174548 · Cited by 25

What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later

Copaescu, A. M., Duque, J. S. R., & Phillips, E. J. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.030 · Cited by 24

Risk of myopericarditis following COVID ‐19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods

Sharff, K. A., Dancoes, D. M., Longueil, J. L., Johnson, E. S., & Lewis, P. F. (2022) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5439 · Cited by 24

Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children

Karatzios, C., Scuccimarri, R., Chédeville, G., Basfar, W., Bullard, J., & Stein, D. R. (2022) · PEDIATRICS · doi:10.1542/peds.2021-055956 · Cited by 24

A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination

Piché‐Renaud, P., Morris, S. K., & Top, K. A. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15625 · Cited by 23

A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2

Singh, T. K., Zidar, D. A., McCrae, K. R., Highland, K. B., Englund, K., Cameron, S. J., & Chung, M. K. (2023) · Circulation Research · doi:10.1161/circresaha.122.322228 · Cited by 26

Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention

Rohner, G. B., Didierlaurent, A. M., Tilmanne, A., Smeesters, P. R., & Marchant, A. (2021) · Vaccines · doi:10.3390/vaccines9091002 · Cited by 28

Incidence of Myopericarditis and Myocardial Injury in Coronavirus Disease 2019 Vaccinated Subjects

Farahmand, R., Trottier, C. A., Kannam, J. P., & Ho, K. K. L. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.10.022 · Cited by 23

CVD and COVID-19: Emerging Roles of Cardiac Fibroblasts and Myofibroblasts

Katwa, L. C., Mendoza, C., & Clements, M. (2022) · Cells · doi:10.3390/cells11081316 · Cited by 23

Acute cardiac side effects after COVID-19 mRNA vaccination: a case series

Freise, N. F., Kivel, M., Grebe, O. C., Meyer, C. G., Wafaisade, B., Peiper, M., Zeus, T., Schmidt, J., Neuwahl, J., Jazmati, D., et al. (2022) · European journal of medical research · doi:10.1186/s40001-022-00695-y · Cited by 26

Multisystem Inflammatory Syndrome

Jayaseelan, K., & Frishman, W. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000487 · Cited by 34

Myocarditis and autoimmunity

Matsumori, A. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2219895 · Cited by 24

COVID-19 vaccine hesitancy and political ideation among college students in Central New York: The influence of differential media choice

Lasher, E. G., Fulkerson, G. M., Seale, E., Thomas, A. R., & Gadomski, A. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101810 · Cited by 22

Addressing COVID-19 vaccine hesitancy

Kassianos, G. C., Puig‐Barberà, J., Dinse, H., Teufel, M., Türeci, Ö., & Pather, S. (2022) · Drugs in Context · doi:10.7573/dic.2021-12-3 · Cited by 22

COVID-19 vaccine-associated myocarditis

Morgan, M. C., Atri, L., Harrell, S., AlJaroudi, W., & Berman, A. E. (2022) · World Journal of Cardiology · doi:10.4330/wjc.v14.i7.382 · Cited by 23

The mosaic of autoimmunity – Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens

Mahroum, N., Elsalti, A., Alwani, A., Seida, I., Alrais, M., Seida, R., Esirgün, S. N., Abali, T., Kiyak, Z., Zoubi, M., et al. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103166 · Cited by 22

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

de Bruyn, G., Wang, J., Purvis, A., Ruiz, M. S., Adhikarla, H., Alvi, S., Bonaparte, M. I., Brune, D., Bueso, A., Canter, R. M., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102109 · Cited by 26

Development of COVID-19 vaccine policy — United States, 2020–2023

Oliver, S. E., Wallace, M. M., Twentyman, E., Moulia, D., Godfrey, M., Link‐Gelles, R., Meyer, S. A., Fleming-Dutra, K. E., Hall, E., Wolicki, J., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.022 · Cited by 24

What Lessons can Be Learned From the Management of the COVID-19 Pandemic?

Quinn, G. A., Connolly, R., ÓhAiseadha, C. O., Hynds, P. D., Bagus, P., Brown, R. B., Cáceres, C. F., Craig, C. E. H., Connolly, M., Domingo, J. L., et al. (2025) · International Journal of Public Health · doi:10.3389/ijph.2025.1607727 · Cited by 24

Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech

Suzuki, M., Sekiguchi, Y., Sasaki, M., Inaba, S., Oyama, S., Inoue, Y., Warabi, M., Ohashi, K., & Inoshita, S. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9807-22 · Cited by 21

Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology

Khawaja, F., Papanicolaou, G. A., Dadwal, S., Pergam, S. A., Wingard, J. R., Boghdadly, Z. E., Abidi, M. Z., Waghmare, A., Shahid, Z., Michaels, L., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.10.010 · Cited by 21

Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine

de Domingo, B., López, M., López-Valladares, M. J., Ortegon-Aguilar, E., Pérez-Argüelles, B. S., & González, F. (2022) · Cells · doi:10.3390/cells11061012 · Cited by 20

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations

Alami, A., Krewski, D. R., Mattison, D. R., Wilson, K. R., Gravel, C. A., Villeneuve, P. J., Farrell, P. J., Crispo, J. A. G., & Perez‐Lloret, S. (2022) · Vaccines · doi:10.3390/vaccines10050722 · Cited by 21

Myocarditis Following COVID-19 Vaccination

Marschner, C., Shaw, K. E., Tijmes, F. S., Fronza, M., Khullar, S., Seidman, M. A., Thavendiranathan, P., Udell, J. A., Wald, R. M., & Hanneman, K. A. (2023) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.08.012 · Cited by 24

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States

Wallace, M. M., Rosenblum, H. G., Moulia, D., Broder, K. R., Shimabukuro, T. T., Taylor, C. A., Havers, F. P., Meyer, S. A., Dooling, K. L., Oliver, S. E., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.07.037 · Cited by 21

Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel

Singapore Armed Forces, S., Tan, J. T., Tan, C. M., Singapore Armed Forces, S., Teoh, J. Y., Singapore Armed Forces, S., Wahab, M. T., Singapore Armed Forces, S., Tan, G. Z., Singapore Armed Forces, S., et al. (2021) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2021345 · Cited by 19

Guidelines for the prevention and management of children and adolescents with COVID-19

Liu, E., Smyth, R. L., Li, Q., Qaseem, A., Flórez, I. D., Mathew, J., Amer, Y. S., Estill, J., Fu, Z., Lü, X., et al. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04615-4 · Cited by 21

Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review

Tofarides, A. G., Christaki, E., Milionis, H. J., & Nikolopoulos, G. K. (2022) · Life · doi:10.3390/life12122057 · Cited by 19

Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis

Kitano, T., Thompson, D. A., Engineer, L. D., Dudley, M. Z., & Salmon, D. A. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad058 · Cited by 19

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence

Hromić‐Jahjefendić, A., Sezer, A., Aljabali, A. A. A., Serrano‐Aroca, Á., Tambuwala, M. M., Uversky, V. N., Redwan, E. M. M. M., Barh, D., & Lundstrom, K. H. (2023) · Biomedicines · doi:10.3390/biomedicines11051469 · Cited by 19

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

Ishisaka, Y., Watanabe, A., Aikawa, T., Kanaoka, K., Takagi, H., Wiley, J., Yasuhara, J., & Kuno, T. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131401 · Cited by 19

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data

van den Ouweland, F., Charpentier, N., Türeci, Ö., Rizzi, R., Mensa, F., Lindemann, C., & Pather, S. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2315659 · Cited by 20

T2 and T2⁎ mapping and weighted imaging in cardiac MRI

Topriceanu, C., Pierce, I., Moon, J., & Captur, G. (2022) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2022.07.012 · Cited by 19

COVID-19 Vaccine Safety First Year Findings in Adolescents

Hesse, E. M., Hause, A. M., Myers, T. R., Su, J. R., Marquez, P., Zhang, B., Cortese, M. M., Thames-Allen, A., Curtis, C. R., Maloney, S. A., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2022-060295 · Cited by 19

Myocarditis or Pericarditis Following the COVID-19 Vaccination in Adolescents: A Systematic Review

Li, M., Wang, X., Feng, J., Feng, Z., Li, W., & Ya, B. (2022) · Vaccines · doi:10.3390/vaccines10081316 · Cited by 18

Vascular and inflammatory diseases after COVID-19 infection and vaccination in children and young people in England: a retrospective, population-based cohort study using linked electronic health records

Sampri, A., Shi, W., Bolton, T. R., Ip, S., Knight, R., Walker, V. M., Denholm, R., Raffetti, E., Keene, S. J., Allara, E., et al. (2025) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(25)00247-0 · Cited by 19

COVID-19 in children and the importance of COVID-19 vaccination

Xue, F.-X., & Shen, K. (2021) · World Journal of Pediatrics · doi:10.1007/s12519-021-00466-5 · Cited by 16

Systematic review and meta-analysis of myocarditis and pericarditis in adolescents following COVID-19 BNT162b2 vaccination

Katoto, P. D., Byamungu, L. N., Brand, A., Tamuzi, J. L., Kakubu, M. A., Wiysonge, C. S., & Gray, G. (2023) · npj Vaccines · doi:10.1038/s41541-023-00681-3 · Cited by 17

The central role of natural killer cells in mediating acute myocarditis after mRNA COVID-19 vaccination

Tsang, H. W., Kwan, M. Y. W., Chua, G. T., Tsao, S. S. L., Wong, J. S. C., Tung, K. T. S., Chan, G. C. F., To, K. K., Wong, I. C. K., Leung, W. H., et al. (2024) · Med · doi:10.1016/j.medj.2024.02.008 · Cited by 17

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

Hu, M., Shoaibi, A., Feng, Y., Lloyd, P. C., Wong, H., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.8192 · Cited by 17

Evaluating the relationship between myocarditis and mRNA vaccination

Switzer, C., & Loeb, M. B. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2002690 · Cited by 17

The Importance of Context in Covid-19 Vaccine Safety

Lee, G. M. (2021) · New England Journal of Medicine · doi:10.1056/nejme2112543 · Cited by 18

Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population

Principi, N., & Esposito, S. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-021-01192-4 · Cited by 16

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines

Rafaniello, C., Gaio, M., Zinzi, A., Sullo, M. G., Liguori, V., Ferraro, M., Petronzelli, F., Felicetti, P., Marchione, P., Marra, A. R., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15050525 · Cited by 16

Efficacy and Safety of COVID-19 Vaccines—An Update

Sharma, E., Revinipati, S., Bhandari, S., Thakur, S., Goyal, S., Ghose, A., Bajpai, S., Muhammad, W., & Boussios, S. (2022) · Diseases · doi:10.3390/diseases10040112 · Cited by 17

Positive Predictive Value of ICD-10-CM Codes for Myocarditis in Claims Data: A Multi-Institutional Study in Taiwan

Wu, L.-Y., Shao, S., & Liao, S. (2023) · Clinical Epidemiology · doi:10.2147/clep.s405660 · Cited by 17

Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study

Shenton, P., Schrader, S., Smith, J., Alafaci, A., Cox, N. R., Taylor, A. J., Hare, J., Jones, B., Crawford, N. W., Buttery, J. P., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.070 · Cited by 17

Cardiovascular Disease Complicating COVID-19 in the Elderly

Dayaramani, C., Leon, J. D., & Reiss, A. B. (2021) · Medicina · doi:10.3390/medicina57080833 · Cited by 16

Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children

Chow, E. J., & Englund, J. A. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2022.01.005 · Cited by 21

Immune Responses against SARS-CoV-2—Questions and Experiences

Mangge, H., Kneihsl, M., Schnedl, W. J., Sendlhofer, G., Curcio, F., & Domenis, R. (2021) · Biomedicines · doi:10.3390/biomedicines9101342 · Cited by 16

Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea

Kim, S., Hwang, I., Ko, M., Kwon, Y., & Lee, Y.-K. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2022.0122 · Cited by 14

Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy

Trivedi, V. S., Magnusen, A. F., Rani, R., Marsili, L., Slavotinek, A. M., Prows, D. R., Hopkin, R. J., McKay, M. A., & Pandey, M. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214340 · Cited by 15

American Society of Echocardiography COVID-19 Statement Update: Lessons Learned and Preparation for Future Pandemics

Kirkpatrick, J. N., Swaminathan, M., Adedipe, A. A., Garcia-Sayan, E. D., Hung, J., Kelly, N., Kort, S., Nagueh, S. F., Poh, K. K., Sarwal, A., et al. (2023) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2023.08.020 · Cited by 15

Post COVID-19 vaccine deaths - Singapore’s early experience

Yeo, A., Kuek, B., Mandy, L. A. U., Tan, S. R., & Chan, S. (2022) · Forensic Science International · doi:10.1016/j.forsciint.2022.111199 · Cited by 18

A case of fulminant myocarditis due to COVID‐19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery

Buitrago, D., Munoz, J., Finkelstein, E. R., & Mulinari, L. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16313 · Cited by 14

Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination

Lane, S., Yeomans, A., & Shakir, S. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060425 · Cited by 16

Parental COVID-19 Vaccine Hesitancy in Diverse Communities: A National Survey

Maurice, A. D. S., Block, R., Sánchez, G. R., & Szilagyi, P. G. (2022) · Academic Pediatrics · doi:10.1016/j.acap.2022.06.016 · Cited by 15

mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study

Kohli, U., Desai, L., Chowdhury, D., Harahsheh, A. S., Yonts, A. B., Ansong, A. K., Sabati, A. A., Nguyen, H. H., Hussain, T., Khan, D. M., et al. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.12.025 · Cited by 14

Myopericarditis After COVID-19 Booster Dose Vaccination

Sharff, K. A., Dancoes, D. M., Longueil, J. L., Lewis, P. F., & Johnson, E. S. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.02.039 · Cited by 14

Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system

Chen, C., Fu, F., Ding, L., Fang, J., & Xiao, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.938322 · Cited by 14

High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302)

Riddler, S. A., Moodie, Z., Clark, J. L., Yen, C., Allen, M., Furch, B. D., Lu, H., Grant, S., Mondal, K., Anderson, M., et al. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-02701 · Cited by 14

Cardiovascular implications of the COVID-19 pandemic

Tomidokoro, D., & Hiroi, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.09.010 · Cited by 15

Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia

Pang, E., Ghosh, S., Chemmanam, T., Grove, C. S., & Phillips, T. J. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-245445 · Cited by 13

Myocarditis Following COVID-19 Vaccination

Marschner, C., Shaw, K. E., Tijmes, F. S., Fronza, M., Khullar, S., Seidman, M. A., Thavendiranathan, P., Udell, J. A., Wald, R. M., & Hanneman, K. A. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2022.05.002 · Cited by 14

Risk of Myopericarditis After COVID-19 Vaccination in Danish Children Aged 5 to 11 Years

Nygaard, U., Holm, M., Dungu, K. H. S., Matthesen, A. T., Stensballe, L. G., Espenhain, L., & Hartling, U. B. (2022) · PEDIATRICS · doi:10.1542/peds.2022-057508 · Cited by 14

Message in a bottle: mRNA vaccination for influenza

Shartouny, J. R., & Lowen, A. C. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001765 · Cited by 15

A Prospective Study on Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination in Healthy Persons

Levi, N., Moravsky, G., Weitsman, T., Amsalem, I., Itach, S. B., Algur, N., Lapidus, I., Mitz, O., Glikson, M., Weil‐Weiner, Y., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2687 · Cited by 14

Fulminant myocarditis following coronavirus disease 2019 vaccination: a case report

Agdamag, A. C., Gonzalez, D., Carlson, K., Konety, S., McDonald, W. C., Martin, C. M., Maharaj, V., & Alexy, T. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac007 · Cited by 13

Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines

Alesci, A., Gitto, M., Kotańska, M., Cascio, P. L., Miller, A., Nicosia, N., Fumia, A., & Pergolizzi, S. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.08.004 · Cited by 14

COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic

Markowitz, L. E., HOPKINS, R. H., Broder, K. R., Lee, G. M., Edwards, K. M., Daley, M. F., Jackson, L. A., Nelson, J. C., Riley, L. E., McNally, V. V., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2023.12.059 · Cited by 13

Effusive–constrictive pericarditis after the second dose of BNT162b2 vaccine (Comirnaty): a case report

Viani, G. M., Pedrotti, P., Seregni, R. G., & Brucato, A. L. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac012 · Cited by 13

The Role of Immunity in the Pathogenesis of SARS-CoV-2 Infection and in the Protection Generated by COVID-19 Vaccines in Different Age Groups

Abdulla, Z. A., Al-Bashir, S. M., Alzoubi, H., Al-Salih, N. S., Aldamen, A. A., & Abdulazeez, A. Z. (2023) · Pathogens · doi:10.3390/pathogens12020329 · Cited by 13

Cardiac arrhythmia in COVID‐19 patients

Yu, L., Liu, Y., & Feng, Y. (2024) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.13105 · Cited by 13

COVID-19 and the heart

Xanthopoulos, A. V., Bourazana, A., Giamouzis, G., Skoularigki, E., Dimos, A. K., Zagouras, A., Papamichalis, M., Leventis, I., Magouliotis, D. E., Triposkiadis, F. K., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i28.9970 · Cited by 13

Overlapping Myocarditis and Postural Orthostatic Tachycardia Syndrome After COVID-19 Messenger RNA Vaccination: A Case Report

Sanada, Y., Azuma, J., Hirano, Y., Hasegawa, Y., & Yamamoto, T. (2022) · Cureus · doi:10.7759/cureus.31006 · Cited by 12

COVID Vaccination in Athletes and Updated Interim Guidance on the Preparticipation Physical Examination During the SARS-Cov-2 Pandemic

Narducci, D. M., Diamond, A. B., Bernhardt, D. T., & Roberts, W. O. (2021) · Clinical Journal of Sport Medicine · doi:10.1097/jsm.0000000000000981 · Cited by 12

The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program

Shiri, T., Evans, M., Talarico, C. A., Morgan, A. R., Mussad, M., Buck, P. O., McEwan, P. C., & Strain, W. D. (2022) · Vaccines · doi:10.3390/vaccines10020140 · Cited by 12

Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force

Tavares, A. C. F. M. G., de Melo, A. K. G., Cruz, V. A., de Souza, V. A., de Carvalho, J. S., Machado, K. L. L. L., Valadares, L. D. D. A., Neto, E. T. D. R., de Rezende, R. P. V., Guimarães, M. F. B. D. R., et al. (2022) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-022-00234-7 · Cited by 13

Clinical Development of mRNA Vaccines: Challenges and Opportunities

August, A., Brito, L., Paris, R., & Zaks, T. Z. (2022) · Current topics in microbiology and immunology · doi:10.1007/82_2022_259 · Cited by 12

Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination

Manno, E. C., Amodio, D., Cotugno, N., Rossetti, C., Giancotta, C., Santilli, V., Zangari, P., Rotulo, G. A., Villani, A., Giglioni, E., et al. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003762 · Cited by 15

Myocardial Inflammation at FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination

Marschner, C., Thavendiranathan, P., Gustafson, D., Howe, K. L., Fish, J. E., Iwanochko, R. M., Wald, R. M., Abdel-Qadir, H. M., Epelman, S., Cheung, A. M., et al. (2023) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.220247 · Cited by 12

Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines

Gedeborg, R., Holm, L., Feltelius, N., Sundström, A., Eggers, K. M., Nurminen, M., Grünewald, M., Pihlström, N., Zethelius, B., & Ljung, R. (2023) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v128.9290 · Cited by 12

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2

Hermosilla, E., Coma, E., Xie, J., Feng, S., Cabezas, C., Méndez-Boo, L., Avilés, F. F., Balló, E., Martínez, M., Medina, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29301-9 · Cited by 12

The benefit of vaccination against COVID-19 outweighs the potential risk of myocarditis and pericarditis

Klamer, T. A., Linschoten, M., & Asselbergs, F. W. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01677-9 · Cited by 10

Myocarditis and pericarditis after COVID-19 messenger RNA vaccines

Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.680117 · Cited by 10

mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation

Fenton, C., & Lee, A. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00956-0 · Cited by 5

Assessment of Pediatric Myocarditis and Pericarditis Complication after mRNA-based COVID-19 Vaccination

Parikh, T. K. (2022) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/cimms/v5/3459c · Cited by 5

Pediatric Myocarditis and Pericarditis Complication after mRNA-based COVID-19 Vaccination

Parikh, T. K. (2022) · Asian Journal of Pediatric Research · doi:10.9734/ajpr/2022/v9i230261 · Cited by 1